Vista normal Vista MARC Vista ISBD

Drug compounding: FDA authority and possible issues for Congress :

Dabrowska, Agata,

Drug compounding: FDA authority and possible issues for Congress : other title information / Agata Dabrowska. - [Library of Congress public edition]. - 1 online resource. - Report / Congressional Research Service ; R45069 . - CRS report ; R45069. .

The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141. CRDP Program record.

Report includes bibliographical references.

LCCN: 2018253011

Subjects--Corporate Names:
United States. Food and Drug Administration.

Subjects--Topical Terms:
Drugs--Dosage forms--Government policy--United States.
Pharmaceutical industry--Government policy--United States.

GPO Item No.: 0807-A-07 (online)

Gov. Doc. Class. No.: LC 14.23:R 45069/

Imprimir
Citar
Agregar a su carrito (remover)
Guardar registro
BIBTEX Dublin Core ISBD MARC (no-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Estándar) MARCXML MODS (XML) RIS
Más búsquedas

Buscar este título en:
HORIZON